Why is Altimmune, Inc. (ALT) stock popping high in Pre-Market trading?
Altimmune, Inc. (ALT), a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies, announced the latest results from a preclinical study observing the ability of its AdCOVID vaccine candidate to neutralize the swift transmission of SARS-CoV-2 B.1.351 strain of concern that originated in South Africa. At last check, shares […]